Prosecution Insights
Last updated: October 04, 2026

Jiangsu Polylive Medtech Co. Ltd.

Technology area: Semiconductors, Circuits & Optics

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Jiangsu Polylive Medtech Co. Ltd. is currently addressing 1 pending office action. This matter falls under the Semiconductors, Circuits & Optics technology area. The prosecution is localized, involving 1 distinct examiner and a distinct art unit, which indicates a singular point of contact within the patent office for the company's current active filings. This arrangement allows for a highly focused legal strategy tailored to a specific technical group.

Le, Thang Xuan serves as the busiest examiner for this portfolio with the pending office action. As this represents the only pending action for the company, the examiner's individual patterns will directly impact the immediate progress of the portfolio. The alignment of the pending action with the art unit reflects a consolidated technical focus. Practitioners should evaluate the examiner's historical allowance rates and common rejections within this specific art unit to prepare for the next phase of prosecution.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
100% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LE, THANG XUAN 1 88.3% +8.8%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18687821 CURRENT PEAK VALUE MEASUREMENT APPARATUS, HIGH VOLTAGE GENERATOR, AND THERAPEUTIC DEVICE FOR VASCULAR CALCIFICATION LE, THANG XUAN 153d overdue

Top Art Units

Art UnitApps
2858 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18687821 CURRENT PEAK VALUE MEASUREMENT APPARATUS, HIGH VOLTAGE GENERATOR, AND THERAPEUTIC DEVICE FOR VASCULAR CALCIFICATION LE, THANG XUAN 2858 §103 Non-Final OA 153d overdue Pending Feb 29, 2024

Managing Jiangsu Polylive Medtech Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month